Hi BM - as other posters have alluded - no science except look at what other similar co's trade at and whether market then views them as under/fair/over valued at the pe.
different industries have hughly different pe's - pharma can have pe in the 20-50's, defensives 10-15, plus div payout ratios can also have an effect, etc
lyc is moving into producer status where pe different from explorer. and i'd use 22kt instead of 11kt - as last presentation states that we will be at stage 2 capacity by next qtr.
looking at another thread where i think Patts had current share price of .60 as 2014 pe of 5x and 2015 pe of 2x - which simply means that as lyc moves to full production - current sp is extremely cheap and patts price target was $2.08 (from memory).
my personal opinion is to use 10x as conservative estimate with current ree price and if forward price estimates trend up/down lyc pe should follow suit.
as i've said - not scientific, but good working guesstimate.
hope this is useful....
what will the p/e ?, page-5
Add LYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.92 |
Change
-0.020(0.29%) |
Mkt cap ! $6.468B | |||
| Open | High | Low | Value | Volume |
| $6.95 | $6.97 | $6.87 | $16.72M | 2.418M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5820 | $6.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.93 | 15020 | 3 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| LYC (ASX) Chart |